Casdin Capital, LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$1.5B
Signature - Title
Steve Giordano - General Counsel
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Casdin Capital, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Casdin Capital, LLC reported 35 stock holdings with total value $1.5B as of Q3 2024. Top holdings included BLFS, RVMD, WGS, LAB, and SRPT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 35 $1.5B +$101M -$49.9M +$50.7M BLFS, RVMD, WGS, LAB, SRPT 13F-HR 11/14/2024, 04:11 PM
Q2 2024 38 $1.31B +$66.2M -$121M -$55.2M BLFS, RVMD, SRPT, LAB, WGS Restatement 10/18/2024, 05:25 PM
Q1 2024 36 $1.34B +$286M -$68.6M +$217M RVMD, LAB, BLFS, SRPT, RLAY 13F-HR 5/15/2024, 04:05 PM
Q4 2023 36 $1.01B +$200M -$140M +$59.9M RVMD, BLFS, SRPT, RLAY, GPCR 13F-HR 2/14/2024, 04:06 PM
Q3 2023 38 $897M +$65.2M -$113M -$48M SRPT, BLFS, EQRX, GPCR, RLAY 13F-HR 11/14/2023, 04:12 PM
Q2 2023 41 $1.14B +$89.8M -$154M -$64.7M BLFS, SRPT, RLAY, EQRX, ALNY 13F-HR 8/14/2023, 03:12 PM
Q1 2023 40 $1.21B +$158M -$195M -$36.8M BLFS, SRPT, RLAY, EQRX, ILMN 13F-HR 5/15/2023, 03:01 PM
Q4 2022 44 $1.28B +$200M -$154M +$46.3M SRPT, BLFS, EQRX, ALNY, ILMN 13F-HR 2/14/2023, 02:01 PM
Q3 2022 36 $1.52B +$277M -$177M +$100M EQRX, BLFS, SRPT, ALNY, BPMC 13F-HR 11/14/2022, 04:18 PM
Q2 2022 40 $1.18B +$49.6M -$498M -$448M EQRX, ALNY, BLFS, RLAY, MXCT 13F-HR 8/15/2022, 01:16 PM
Q1 2022 47 $2.23B +$29.3M -$331M -$301M BLFS, ALNY, EQRX, FATE, RLAY 13F-HR 5/16/2022, 12:32 PM
Q4 2021 53 $3.55B +$441M -$198M +$243M BLFS, EQRX, FATE, NVTAQ, ALNY 13F-HR 2/14/2022, 11:19 AM
Q3 2021 53 $4.01B +$852M -$170M +$681M NVTAQ, BLFS, EXAS, PACB, FATE 13F-HR 11/15/2021, 03:15 PM
Q2 2021 54 $3.94B +$603M -$90.3M +$513M NVTAQ, BLFS, FATE, EXAS, VERV 13F-HR 8/16/2021, 01:56 PM
Q1 2021 48 $3.36B +$338M -$163M +$175M NVTAQ, EXAS, FATE, BLFS, PACB 13F-HR 5/17/2021, 02:48 PM
Q4 2020 50 $3.36B +$685M -$169M +$516M NVTAQ, BLFS, FATE, EXAS, BPMC 13F-HR 2/16/2021, 01:36 PM
Q3 2020 45 $2.23B +$382M -$48.5M +$334M NVTAQ, BLFS, RLAY, BPMC, FATE 13F-HR 11/16/2020, 02:34 PM
Q2 2020 42 $1.69B +$420M -$105M +$316M NVTAQ, BPMC, FATE, SRPT, MYOK 13F-HR 8/14/2020, 04:39 PM
Q1 2020 38 $942M +$201M -$75.7M +$125M BPMC, SRPT, ALNY, FATE, CDXS 13F-HR 5/15/2020, 02:02 PM
Q4 2019 31 $1.07B +$83.4M -$189M -$105M SRPT, BLUE, CDXS, BPMC, MYOK 13F-HR 2/14/2020, 04:35 PM
Q3 2019 33 $966M +$118M -$20.1M +$97.8M ONCE, NVTAQ, CDXS, BPMC, SRPT Restatement 1/3/2020, 09:58 AM
Q2 2019 31 $1.07B +$199M -$29.1M +$170M ONCE, NVTAQ, BPMC, CDXS, SAGE 13F-HR 8/13/2019, 02:11 PM
Q1 2019 29 $910M +$122M -$77.5M +$44.1M ONCE, BPMC, MYOK, SAGE, BLUE 13F-HR 5/15/2019, 03:08 PM
Q4 2018 31 $585M +$51.8M -$66.7M -$14.9M LOXO, MYOK, BPMC, CDXS, ONCE 13F-HR 2/13/2019, 04:42 PM
Q3 2018 34 $814M +$182M -$101M +$81M LOXO, BPMC, MYOK, AGIO, SAGE 13F-HR 11/14/2018, 10:33 AM
Q2 2018 32 $709M +$124M -$34M +$90.2M FMI, LOXO, BPMC, SAGE, MYOK Restatement 8/20/2018, 04:16 PM
Q1 2018 30 $565M +$92M -$6.4M +$85.6M LOXO, FMI, SAGE, BPMC, ONCE 13F-HR 5/15/2018, 12:01 PM
Q4 2017 26 $409M +$53.1M -$24.5M +$28.6M SAGE, FMI, LOXO, BPMC, BLUE 13F-HR 2/14/2018, 08:00 AM
Q3 2017 26 $354M +$65.8M -$18.5M +$47.4M LOXO, MYOK, ALNY, SGMO, BPMC 13F-HR 11/14/2017, 08:16 AM
Q2 2017 31 $250M +$68.4M -$10.9M +$57.5M LOXO, SAGE, FMI, BPMC, EVH 13F-HR 8/14/2017, 10:05 AM
Q1 2017 29 $170M +$36.1M -$33.3M +$2.8M SAGE, FMI, LOXO, AGIO, BPMC 13F-HR 5/15/2017, 02:36 PM
Q4 2016 25 $121M +$30.9M -$20.7M +$10.2M SAGE, LOXO, AGIO, FMI, EVH 13F-HR 2/14/2017, 01:01 PM
Q3 2016 26 $123M +$27.9M -$28.5M -$596K AGIO, SAGE, FMI, EVH, BPMC 13F-HR 11/14/2016, 01:20 PM
Q2 2016 24 $95.7M +$25.7M -$18.6M +$7.12M ONCE, AGIO, FMI, GBT, LOXO 13F-HR 8/15/2016, 12:45 PM
Q1 2016 25 $84.5M +$26.3M -$19.8M +$6.47M LOXO, EPZM, FMI, SAGE, AGIO 13F-HR 5/9/2016, 11:41 AM
Q4 2015 27 $107M $0 $0 BPMC, SAGE, LOXO, CTMX, ONCE 13F-HR 2/8/2016, 07:33 AM